TrialQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2020

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Richard G B Langley et al.PubMed ↗Publisher ↗

No numbers read from the abstract.